Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bushara, KO; Wheat, JM; Khan, A; Mock, BJ; Turski, PA; Sorenson, J; Brooks, BR
   Multiple tactile maps in the human cerebellum
   NEUROREPORT
   
   K.O. Bushara et al., "Multiple tactile maps in the human cerebellum", NEUROREPORT, 12(11), 2001, pp. 2483-2486
2. Sanjak, M; Brinkmann, J; Belden, DS; Roelke, K; Waclawik, A; Neville, HE; Ringel, SP; Murphy, JR; Brooks, BR
   Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis
   JOURNAL OF THE NEUROLOGICAL SCIENCES
   
   M. Sanjak et al., "Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis", J NEUR SCI, 191(1-2), 2001, pp. 55-59
3. Speelman, B; Brooks, BR; Post, CB
   Molecular dynamics simulations of human rhinovirus and an antiviral compound
   BIOPHYSICAL JOURNAL
   
   B. Speelman et al., "Molecular dynamics simulations of human rhinovirus and an antiviral compound", BIOPHYS J, 80(1), 2001, pp. 121-129
4. Brooks, BR; Sanjak, M; Belden, D; Waclawik, A
   Motor neurone disease: Basic designs, sample sizes and pitfalls
   CLINICAL TRIALS IN NEUROLOGY
   
   B.R. Brooks et al., "Motor neurone disease: Basic designs, sample sizes and pitfalls", CLINICAL TRIALS IN NEUROLOGY, 2001, pp. 427-450
5. Brooks, BR; Miller, RG; Swash, M; Munsat, TL
   El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
   AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
   
   B.R. Brooks et al., "El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis", AMYOTROPH L, 1(5), 2000, pp. 293-299
6. Brooks, BR; Juhasz-Poscine, K; Waclawik, A; Sanjak, M; Belden, D; Roelke, K; Parnell, J; Weasler, C
   Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists
   AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
   
   B.R. Brooks et al., "Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists", AMYOTROPH L, 1, 2000, pp. 45-53
7. Brooks, BR; Bushara, K; Khan, A; Hershberger, J; Wheat, JO; Belden, D; Henningsen, H
   Functional magnetic resonance imaging (fMRI) clinical studies in ALS - paradigms, problems and promises
   AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
   
   B.R. Brooks et al., "Functional magnetic resonance imaging (fMRI) clinical studies in ALS - paradigms, problems and promises", AMYOTROPH L, 1, 2000, pp. S23-S32
8. Brooks, BR
   Debating the possibility of earlier diagnosis of patients with amyotrophiclateral sclerosis
   AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
   
   B.R. Brooks, "Debating the possibility of earlier diagnosis of patients with amyotrophiclateral sclerosis", AMYOTROPH L, 1, 2000, pp. S1-S2
9. Brooks, BR
   Risk factors in the early diagnosis of ALS: North American epidemiologicalstudies
   AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
   
   B.R. Brooks, "Risk factors in the early diagnosis of ALS: North American epidemiologicalstudies", AMYOTROPH L, 1, 2000, pp. S19-S26
10. Brooks, BR
    Versailles minimal dataset for diagnosis of ALS: a distillate of the 2nd Consensus Conference on accelerating the diagnosis of ALS
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    
    B.R. Brooks, "Versailles minimal dataset for diagnosis of ALS: a distillate of the 2nd Consensus Conference on accelerating the diagnosis of ALS", AMYOTROPH L, 1, 2000, pp. S79-S81
11. Johnson, KP; Brooks, BR; Ford, CC; Goodman, A; Guarnaccia, J; Lisak, RP; Myers, LW; Panitch, HS; Pruitt, A; Rose, JW; Kachuck, N; Wolinsky, JS
    Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years
    MULTIPLE SCLEROSIS
    
    K.P. Johnson et al., "Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years", MULT SCLER, 6(4), 2000, pp. 255-266
12. Miller, RG; Anderson, FA; Bradley, WG; Brooks, BR; Mitsumoto, H; Munsat, TL; Ringel, SP
    The ALS Patient Care Database - Goals, design, and early results
    NEUROLOGY
    
    R.G. Miller et al., "The ALS Patient Care Database - Goals, design, and early results", NEUROLOGY, 54(1), 2000, pp. 53-57
13. Szurek, PF; Brooks, BR
    Synthesis of virus-specific high-mobility DNA after temperature upshift ofSC-1 cells chronically infected with moloney murine leukemia virus mutant ts1
    JOURNAL OF VIROLOGY
    
    P.F. Szurek e B.R. Brooks, "Synthesis of virus-specific high-mobility DNA after temperature upshift ofSC-1 cells chronically infected with moloney murine leukemia virus mutant ts1", J VIROLOGY, 74(15), 2000, pp. 7055-7063
14. Zhou, J; Reich, S; Brooks, BR
    Elastic molecular dynamics with self-consistent flexible constraints
    JOURNAL OF CHEMICAL PHYSICS
    
    J. Zhou et al., "Elastic molecular dynamics with self-consistent flexible constraints", J CHEM PHYS, 112(18), 2000, pp. 7919-7929
15. Venable, RM; Brooks, BR; Pastor, RW
    Molecular dynamics simulations of gel (L-beta I) phase lipid bilayers in constant pressure and constant surface area ensembles
    JOURNAL OF CHEMICAL PHYSICS
    
    R.M. Venable et al., "Molecular dynamics simulations of gel (L-beta I) phase lipid bilayers in constant pressure and constant surface area ensembles", J CHEM PHYS, 112(10), 2000, pp. 4822-4832
16. Waclawik, AJ; Vann, J; Schmelz, G; Szurek, P; Lewandoski, P; Brooks, BR
    Zidovudine [AZT] myotoxicity: Quantitative separation of AZT effects on proliferation and differentiation of muscle cells in vitro. Lack of myotoxicity potentiation by retrovirus
    NEUROTOXICOLOGY
    
    A.J. Waclawik et al., "Zidovudine [AZT] myotoxicity: Quantitative separation of AZT effects on proliferation and differentiation of muscle cells in vitro. Lack of myotoxicity potentiation by retrovirus", NEUROTOXICO, 20(1), 1999, pp. 49-56
17. Miller, RG; Rosenberg, JA; Gelinas, DF; Mitsumoto, H; Newman, D; Sufit, R; Borasio, GD; Bradley, WG; Bromberg, MB; Brooks, BR; Kasarskis, EJ; Munsat, TL; Oppenheimer, EA
    Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review)
    MUSCLE & NERVE
    
    R.G. Miller et al., "Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review)", MUSCLE NERV, 22(8), 1999, pp. 1104-1118
18. Brooks, BR
    Defining optimal management in ALS: from first symptoms to announcement - Introduction
    NEUROLOGY
    
    B.R. Brooks, "Defining optimal management in ALS: from first symptoms to announcement - Introduction", NEUROLOGY, 53(8), 1999, pp. S1-S3
19. Brooks, BR
    What are the implications of early diagnosis? Maintaining optimal health as long as possible
    NEUROLOGY
    
    B.R. Brooks, "What are the implications of early diagnosis? Maintaining optimal health as long as possible", NEUROLOGY, 53(8), 1999, pp. S43-S45
20. Brooks, BR
    Earlier is better: the benefits of early diagnosis
    NEUROLOGY
    
    B.R. Brooks, "Earlier is better: the benefits of early diagnosis", NEUROLOGY, 53(8), 1999, pp. S53-S54
21. Brooks, BR
    Closing remarks
    NEUROLOGY
    
    B.R. Brooks, "Closing remarks", NEUROLOGY, 53(8), 1999, pp. S72-S72
22. Miller, RG; Rosenberg, JA; Gelinas, NF; Mitsumoto, H; Newman, D; Sufit, R; Borasio, GD; Bradley, WG; Bromberg, MB; Brooks, BR; Kasarskis, EJ; Munsat, TL; Oppenheimer, EA
    Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
    NEUROLOGY
    
    R.G. Miller et al., "Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology", NEUROLOGY, 52(7), 1999, pp. 1311-1323
23. Kasarskis, EJ; Shefner, JM; Miller, R; Smith, RA; Licht, J; Mitsumoto, H; Hopkins, LC; Rosenfeld, J; Pascuzzi, R; Cornblath, DR; Armon, C; Strong, MJ; Kula, R; Windebank, A; Bosch, EP; Smith, BE; Cashman, N; Sivak, M; Sergay, S; Siddique, T; Sufit, RL; Johnston, W; Brooke, MB; Graves, MC; Olney, RK; Roos, RP; Neville, H; Ringel, SP; Ross, M; Bradley, WG; Sharma, KR; Parry, G; Mandler, R; Giuliani, M; Thornton, CA; Jackson, C; Bryan, W; Bromberg, M; Tandan, R; Fries, T; Phillips, L; Brooks, BR; Fenichel, G; Pestronk, A; Bear, M; Beatey, R; Fuller, C; Hill, R; Malta, E; Nakanishi, A; Patel, A; Thurmond, B; Cedarbaum, JM; Stambler, N
    A controlled trial of recombinant methionyl human BDNF in ALS
    NEUROLOGY
    
    E.J. Kasarskis et al., "A controlled trial of recombinant methionyl human BDNF in ALS", NEUROLOGY, 52(7), 1999, pp. 1427-1433
24. Miller, RG; Munsat, TL; Swash, M; Brooks, BR
    Consensus guidelines far the design and implementation of clinical trials in ALS
    JOURNAL OF THE NEUROLOGICAL SCIENCES
    
    R.G. Miller et al., "Consensus guidelines far the design and implementation of clinical trials in ALS", J NEUR SCI, 169(1-2), 1999, pp. 2-12
25. Brooks, BR
    Diagnostic dilemmas in amyotrophic lateral sclerosis
    JOURNAL OF THE NEUROLOGICAL SCIENCES
    
    B.R. Brooks, "Diagnostic dilemmas in amyotrophic lateral sclerosis", J NEUR SCI, 165, 1999, pp. S1-S9
26. CHEATHAM TE; BROOKS BR
    RECENT ADVANCES IN MOLECULAR-DYNAMICS SIMULATION TOWARDS THE REALISTIC REPRESENTATION OF BIOMOLECULES IN SOLUTION
    Theoretical Chemistry accounts ( Theoretical Chemistry accounts (Print))
    
    T.E. Cheatham e B.R. Brooks, "RECENT ADVANCES IN MOLECULAR-DYNAMICS SIMULATION TOWARDS THE REALISTIC REPRESENTATION OF BIOMOLECULES IN SOLUTION", Theoretical Chemistry accounts ( Theoretical Chemistry accounts (Print)), 99(5), 1998, pp. 279-288
27. Ford, CC; Brooks, BR; Johnson, KP; Lisak, RP; Myers, LW; Panitch, HS; Rose, JW; Schiffer, RB; Vollmer, T; Weiner, LP; Wolinsky, JS
    Sustained efficacy of glatiramer acetate for injection in a 5+ year trial of relapsing remitting MS
    MULTIPLE SCLEROSIS
    
    C.C. Ford et al., "Sustained efficacy of glatiramer acetate for injection in a 5+ year trial of relapsing remitting MS", MULT SCLER, 4(6), 1998, pp. 521-521
28. CEDARBAUM JM; STAMBLER N; BROOKS BR; BRADLEY W
    BRAIN-DERIVED NEUROTROPHIC FACTOR IN AMYOTROPHIC-LATERAL-SCLEROSIS - A FAILED DRUG OR A FAILED TRIAL
    Annals of neurology
    
    J.M. Cedarbaum et al., "BRAIN-DERIVED NEUROTROPHIC FACTOR IN AMYOTROPHIC-LATERAL-SCLEROSIS - A FAILED DRUG OR A FAILED TRIAL", Annals of neurology, 44(3), 1998, pp. 255-255
29. LEE YS; HODOSCEK M; BROOKS BR; KADOR PF
    CATALYTIC MECHANISM OF ALDOSE REDUCTASE STUDIED BY THE COMBINED POTENTIALS OF QUANTUM-MECHANICS AND MOLECULAR MECHANICS
    Biophysical chemistry
    
    Y.S. Lee et al., "CATALYTIC MECHANISM OF ALDOSE REDUCTASE STUDIED BY THE COMBINED POTENTIALS OF QUANTUM-MECHANICS AND MOLECULAR MECHANICS", Biophysical chemistry, 70(3), 1998, pp. 203-216
30. CHATFIELD DC; EURENIUS KP; BROOKS BR
    HIV-1 PROTEASE CLEAVAGE MECHANISM - A THEORETICAL INVESTIGATION BASEDON CLASSICAL MD SIMULATION AND REACTION-PATH CALCULATIONS USING A HYBRID QM MM POTENTIAL/
    Journal of molecular structure. Theochem
    
    D.C. Chatfield et al., "HIV-1 PROTEASE CLEAVAGE MECHANISM - A THEORETICAL INVESTIGATION BASEDON CLASSICAL MD SIMULATION AND REACTION-PATH CALCULATIONS USING A HYBRID QM MM POTENTIAL/", Journal of molecular structure. Theochem, 423(1-2), 1998, pp. 79-92
31. SIDDIQUE T; HONG S; BROOKS BR; HUNG WY; SIDDIQUE NA; RIMMLER J; KAPLAN JP; HAINES JL; BROWN RH; PERICAK MA
    X-LINKED DOMINANT ALS
    Neurology
    
    T. Siddique et al., "X-LINKED DOMINANT ALS", Neurology, 51(1), 1998, pp. 1-1
32. DIXIT SN; DOGAN S; BROOKS BR
    COMPUTERIZED TREMOR TESTING IN MULTIPLE-SCLEROSIS [MS] - TREMOR PREVALENCE, TYPE, LONGITUDINAL EVOLUTION AND RESPONSE TO TREATMENT IN 185 PATIENTS
    Neurology
    
    S.N. Dixit et al., "COMPUTERIZED TREMOR TESTING IN MULTIPLE-SCLEROSIS [MS] - TREMOR PREVALENCE, TYPE, LONGITUDINAL EVOLUTION AND RESPONSE TO TREATMENT IN 185 PATIENTS", Neurology, 50(4), 1998, pp. 4037-4037
33. KHAN A; FERNANDEZSCHMIDT D; BUSHARA K; BALDEN DS; MOCK B; SORENSON J; TURSKI P; BROOKS BR
    DIFFERENTIAL SENSORIMOTOR CORTEX (SMC) ACTIVATION FOLLOWING CUTANEOUSSTIMULATION OF THE HAND AND FOOT IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - THE EFFECT OF THE BABINSKI RESPONSE - A FUNCTIONAL MAGNETIC-RESONANCE-IMAGING (FMRI) STUDY
    Neurology
    
    A. Khan et al., "DIFFERENTIAL SENSORIMOTOR CORTEX (SMC) ACTIVATION FOLLOWING CUTANEOUSSTIMULATION OF THE HAND AND FOOT IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - THE EFFECT OF THE BABINSKI RESPONSE - A FUNCTIONAL MAGNETIC-RESONANCE-IMAGING (FMRI) STUDY", Neurology, 50(4), 1998, pp. 34004-34004
34. JOHNSON KP; BROOKS BR; COHEN JA; FORD CC; GOLDSTEIN J; LISAK RP; MYERS LW; PANITCH HS; ROSE JW; SCHIFFER RB; VOLLMER T; WEINER LP; WOLINSKY JS
    EXTENDED USE OF GLATIRAMER ACETATE (COPAXONE) IS WELL TOLERATED AND MAINTAINS ITS CLINICAL EFFECT ON MULTIPLE-SCLEROSIS RELAPSE RATE AND DEGREE OF DISABILITY
    Neurology
    
    K.P. Johnson et al., "EXTENDED USE OF GLATIRAMER ACETATE (COPAXONE) IS WELL TOLERATED AND MAINTAINS ITS CLINICAL EFFECT ON MULTIPLE-SCLEROSIS RELAPSE RATE AND DEGREE OF DISABILITY", Neurology, 50(3), 1998, pp. 701-708
35. BOGUSZ S; CHEATHAM TE; BROOKS BR
    REMOVAL OF PRESSURE AND FREE-ENERGY ARTIFACTS IN CHARGED PERIODIC-SYSTEMS VIA NET CHARGE CORRECTIONS TO THE EWALD POTENTIAL
    The Journal of chemical physics
    
    S. Bogusz et al., "REMOVAL OF PRESSURE AND FREE-ENERGY ARTIFACTS IN CHARGED PERIODIC-SYSTEMS VIA NET CHARGE CORRECTIONS TO THE EWALD POTENTIAL", The Journal of chemical physics, 108(17), 1998, pp. 7070-7084
36. ENYEDY IJ; KOVACH IM; BROOKS BR
    ALTERNATE PATHWAYS FOR ACETIC-ACID AND ACETATE ION RELEASE FROM ACETYLCHOLINESTERASE - A MOLECULAR-DYNAMICS STUDY
    Journal of the American Chemical Society
    
    I.J. Enyedy et al., "ALTERNATE PATHWAYS FOR ACETIC-ACID AND ACETATE ION RELEASE FROM ACETYLCHOLINESTERASE - A MOLECULAR-DYNAMICS STUDY", Journal of the American Chemical Society, 120(32), 1998, pp. 8043-8050
37. CHATFIELD DC; SZABO A; BROOKS BR
    MOLECULAR-DYNAMICS OF STAPHYLOCOCCAL NUCLEASE - COMPARISON OF SIMULATION WITH N-15 AND C-13 NMR RELAXATION DATA
    Journal of the American Chemical Society
    
    D.C. Chatfield et al., "MOLECULAR-DYNAMICS OF STAPHYLOCOCCAL NUCLEASE - COMPARISON OF SIMULATION WITH N-15 AND C-13 NMR RELAXATION DATA", Journal of the American Chemical Society, 120(21), 1998, pp. 5301-5311
38. LIU Y; BROOKS BR; TANIGUCHI N; HARTMANN HA
    CUZNSOD AND MNSOD IMMUNOREACTIVITY IN BRAIN-STEM MOTOR-NEURONS FROM AMYOTROPIC LATERAL SCLEROSIS PATIENTS
    Acta Neuropathologica
    
    Y. Liu et al., "CUZNSOD AND MNSOD IMMUNOREACTIVITY IN BRAIN-STEM MOTOR-NEURONS FROM AMYOTROPIC LATERAL SCLEROSIS PATIENTS", Acta Neuropathologica, 95(1), 1998, pp. 63-70
39. BUSHARA KO; WHEAT JM; MOCK BJ; BELDEN DS; HENNINGSEN H; CORDES D; BERNSTEIN Z; SORENSON JA; TURSKI PA; BROOKS BR
    SOMATOSENSORY REPRESENTATION OF THE HAND IN 2 SEPARATE AREAS OF THE HUMAN CEREBELLUM
    Annals of neurology
    
    K.O. Bushara et al., "SOMATOSENSORY REPRESENTATION OF THE HAND IN 2 SEPARATE AREAS OF THE HUMAN CEREBELLUM", Annals of neurology, 42(3), 1997, pp. 101-101
40. BROOKS BR; SHODIS KA; LOTTO M; SANJAK M; ROELKE K; BELDEN D; PARNELL J; DEWITT C; WHEAT K
    ECONOMIC-DEPENDENT, CAREGIVER-DEPENDENT, AND VENTILATOR-DEPENDENT STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS - PROSPECTIVE CORRELATION WITH ALS FUNCTIONAL RATING-SCALE, ISOMETRIC MUSCLE STRENGTH, PULMONARY-FUNCTION, SF-36, AND SICKNESS IMPACT PROFILE QUALITY-OF-LIFE MEASURES
    Annals of neurology
    
    B.R. Brooks et al., "ECONOMIC-DEPENDENT, CAREGIVER-DEPENDENT, AND VENTILATOR-DEPENDENT STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS - PROSPECTIVE CORRELATION WITH ALS FUNCTIONAL RATING-SCALE, ISOMETRIC MUSCLE STRENGTH, PULMONARY-FUNCTION, SF-36, AND SICKNESS IMPACT PROFILE QUALITY-OF-LIFE MEASURES", Annals of neurology, 42(3), 1997, pp. 311-311
41. PARRY CS; BROOKS BR; MATSUNAGA N; AMZEL LM
    STRUCTURES OF SOME SUBSTITUTED NITROPHENOLS DETERMINED BY AB-INITIO COMPUTATION - ON THE ORIGIN OF HETEROCLITICITY IN ANTI-NITROPHENOL ANTIBODIES
    Journal of molecular structure. Theochem
    
    C.S. Parry et al., "STRUCTURES OF SOME SUBSTITUTED NITROPHENOLS DETERMINED BY AB-INITIO COMPUTATION - ON THE ORIGIN OF HETEROCLITICITY IN ANTI-NITROPHENOL ANTIBODIES", Journal of molecular structure. Theochem, 398, 1997, pp. 555-563
42. FADIC R; WACLAWIK AJ; BROOKS BR; LOTZ BP
    THE RIGID SPINE SYNDROME DUE TO ACID MALTASE DEFICIENCY
    Muscle & nerve
    
    R. Fadic et al., "THE RIGID SPINE SYNDROME DUE TO ACID MALTASE DEFICIENCY", Muscle & nerve, 20(3), 1997, pp. 364-366
43. JUHASZPOCSINE K; WACLAWIK AJ; GLINSKI L; DENG HX; KAPLAN J; CALIENDO J; SIDDIQUE T; BROOKS BR
    CLINICOPATHOLOGICAL PHENOTYPE OF FAMILIAL ALS WITH A NOVEL EXON-4 CODON-100 SOD1 GENE MUTATION IN AN AFRO-AMERICAN FAMILY
    Neurology
    
    K. Juhaszpocsine et al., "CLINICOPATHOLOGICAL PHENOTYPE OF FAMILIAL ALS WITH A NOVEL EXON-4 CODON-100 SOD1 GENE MUTATION IN AN AFRO-AMERICAN FAMILY", Neurology, 48(3), 1997, pp. 2110-2110
44. WACLAWIK AJ; LOTZ BP; SALAMAT SM; BEINLICH BR; BROOKS BR
    MYOPATHIC DROPPED HEAD SYNDROME - AN EXPANDING CLINICOPATHOLOGICAL SPECTRUM
    Neurology
    
    A.J. Waclawik et al., "MYOPATHIC DROPPED HEAD SYNDROME - AN EXPANDING CLINICOPATHOLOGICAL SPECTRUM", Neurology, 48(3), 1997, pp. 6142-6142
45. BUSHARA KO; HENNINGSEN H; WHEAT JM; MOCK BJ; LOWE MJ; TURSKI PA; SORENSEN JA; BROOKS BR
    DECREASED CORTICAL ACTIVATION DURING SENSORY STIMULATION IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - A FUNCTIONAL MAGNETIC-RESONANCE (FMRI) STUDY
    Neurology
    
    K.O. Bushara et al., "DECREASED CORTICAL ACTIVATION DURING SENSORY STIMULATION IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - A FUNCTIONAL MAGNETIC-RESONANCE (FMRI) STUDY", Neurology, 48(3), 1997, pp. 29004-29004
46. WACLAWIK AJ; LOTZ BP; BEINLICH BR; BROOKS BR
    DROPPED HEAD SYNDROME
    Neurology
    
    A.J. Waclawik et al., "DROPPED HEAD SYNDROME", Neurology, 48(2), 1997, pp. 550-551
47. STEINBACH PJ; BROOKS BR
    DYNAMICS OF MYOGLOBIN IN SOLUTION SIMULATED AT MULTIPLE TEMPERATURES
    Biophysical journal
    
    P.J. Steinbach e B.R. Brooks, "DYNAMICS OF MYOGLOBIN IN SOLUTION SIMULATED AT MULTIPLE TEMPERATURES", Biophysical journal, 72(2), 1997, pp. 468-468
48. BROOKS BR
    EMERGING DIRECTIONS IN ALS THERAPEUTICS - PALLIATIVE THERAPIES AT THEADVENT OF THE 21ST-CENTURY
    Clinical neuroscience
    
    B.R. Brooks, "EMERGING DIRECTIONS IN ALS THERAPEUTICS - PALLIATIVE THERAPIES AT THEADVENT OF THE 21ST-CENTURY", Clinical neuroscience, 3(6), 1996, pp. 386-392
49. BHATTACHARYYA D; BROOKS BR; CALLAHAN L
    POSITIONING OF POSITIVELY CHARGED RESIDUES IN THE V3 LOOP CORRELATES WITH HIV TYPE-1 SYNCYTIUM-INDUCING PHENOTYPE
    AIDS research and human retroviruses
    
    D. Bhattacharyya et al., "POSITIONING OF POSITIVELY CHARGED RESIDUES IN THE V3 LOOP CORRELATES WITH HIV TYPE-1 SYNCYTIUM-INDUCING PHENOTYPE", AIDS research and human retroviruses, 12(2), 1996, pp. 83-90
50. BROOKS BR
    CLINICAL EPIDEMIOLOGY OF AMYOTROPHIC-LATERAL-SCLEROSIS
    Neurologic clinics
    
    B.R. Brooks, "CLINICAL EPIDEMIOLOGY OF AMYOTROPHIC-LATERAL-SCLEROSIS", Neurologic clinics, 14(2), 1996, pp. 399
51. STRONG M; ROTHSTEIN JD; FELDMAN E; CLEVELAND D; BROOKS BR
    EXCITOTOXICITY HYPOTHESIS - DISCUSSION
    Neurology
    
    M. Strong et al., "EXCITOTOXICITY HYPOTHESIS - DISCUSSION", Neurology, 47(4), 1996, pp. 26-26
52. MITSUMOTO H; SMITH RG; DRACHMAN D; BROOKS BR
    AUTOIMMUNITY AND ALS - DISCUSSION
    Neurology
    
    H. Mitsumoto et al., "AUTOIMMUNITY AND ALS - DISCUSSION", Neurology, 47(4), 1996, pp. 45-46
53. BROOKS BR
    NATURAL-HISTORY OF ALS - SYMPTOMS, STRENGTH, PULMONARY-FUNCTION, AND DISABILITY
    Neurology
    
    B.R. Brooks, "NATURAL-HISTORY OF ALS - SYMPTOMS, STRENGTH, PULMONARY-FUNCTION, AND DISABILITY", Neurology, 47(4), 1996, pp. 71-81
54. MITSUMOTO H; BROOKS BR; HAVERKAMP L; MILLER RG
    NATURAL-HISTORY OF ALS - SYMPTOMS, STRENGTH, PULMONARY-FUNCTION, AND DISABILITY - DISCUSSION
    Neurology
    
    H. Mitsumoto et al., "NATURAL-HISTORY OF ALS - SYMPTOMS, STRENGTH, PULMONARY-FUNCTION, AND DISABILITY - DISCUSSION", Neurology, 47(4), 1996, pp. 81-82
55. GUTMAN L; MUNSAT TL; HAVERKAMP L; BROOKS BR; JOHNSTON W
    DEVELOPMENT OF MEASUREMENT TECHNIQUES - DISCUSSION
    Neurology
    
    L. Gutman et al., "DEVELOPMENT OF MEASUREMENT TECHNIQUES - DISCUSSION", Neurology, 47(4), 1996, pp. 85-85
56. BROMBERG MB; BROOKS BR
    ISSUES IN CLINICAL-TRIAL DESIGN .2. SELECTION OF END-POINT MEASURES
    Neurology
    
    M.B. Bromberg e B.R. Brooks, "ISSUES IN CLINICAL-TRIAL DESIGN .2. SELECTION OF END-POINT MEASURES", Neurology, 47(4), 1996, pp. 100-102
57. GUTMANN L; DRACHMAN D; MUNSAT TL; BROOKE MH; LAI E; MILLER RG; GAWEL M; SUMNER AJ; MITSUMOTO H; BROOKS BR; GELINAS D; JOHNSTON W
    COMMUNICATIONS AND ALS TRIAL - INFORMATION SHARING
    Neurology
    
    L. Gutmann et al., "COMMUNICATIONS AND ALS TRIAL - INFORMATION SHARING", Neurology, 47(4), 1996, pp. 130-135
58. HERSHBERGER JE; BROOKS BR; LOWE MJ; MOCK BJ; WANG X; TURSKI PA; SORENSEN JA; BERNSTEIN Z
    EVALUATION OF UPPER MOTOR-NEURON PHYSIOLOGICAL TESTS FOR FUNCTIONAL MAGNETIC-RESONANCE-IMAGING ASSESSMENT OF CORTICAL ACTIVATION PATTERNS IN AMYOTROPHIC-LATERAL-SCLEROSIS - DEVELOPMENT OF TEST PARADIGMS FOR LONGITUDINAL-STUDIES
    Neurology
    
    J.E. Hershberger et al., "EVALUATION OF UPPER MOTOR-NEURON PHYSIOLOGICAL TESTS FOR FUNCTIONAL MAGNETIC-RESONANCE-IMAGING ASSESSMENT OF CORTICAL ACTIVATION PATTERNS IN AMYOTROPHIC-LATERAL-SCLEROSIS - DEVELOPMENT OF TEST PARADIGMS FOR LONGITUDINAL-STUDIES", Neurology, 46(2), 1996, pp. 2133-2133
59. BROOKS BR
    PROGNOSTIC INDICATORS OF SURVIVAL IN AMYOTROPHIC-LATERAL-SCLEROSIS
    Neurology
    
    B.R. Brooks, "PROGNOSTIC INDICATORS OF SURVIVAL IN AMYOTROPHIC-LATERAL-SCLEROSIS", Neurology, 46(2), 1996, pp. 2135-2135
60. DIXIT S; BUSHARA K; BROOKS BR
    EPIDEMIC HEAT-STROKE IN A MIDWEST COMMUNITY - RISK-FACTORS, NEUROLOGIC COMPLICATIONS, AND SEQUELAE
    Neurology
    
    S. Dixit et al., "EPIDEMIC HEAT-STROKE IN A MIDWEST COMMUNITY - RISK-FACTORS, NEUROLOGIC COMPLICATIONS, AND SEQUELAE", Neurology, 46(2), 1996, pp. 3051-3051
61. STEINBACH PJ; BROOKS BR
    HYDRATED MYOGLOBINS ANHARMONIC FLUCTUATIONS ARE NOT PRIMARILY DUE TO DIHEDRAL TRANSITIONS
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    P.J. Steinbach e B.R. Brooks, "HYDRATED MYOGLOBINS ANHARMONIC FLUCTUATIONS ARE NOT PRIMARILY DUE TO DIHEDRAL TRANSITIONS", Proceedings of the National Academy of Sciences of the United Statesof America, 93(1), 1996, pp. 55-59
62. SZUREK PF; BROOKS BR
    TS1-INDUCED SPONGIFORM ENCEPHALOMYELOPATHY - PHYSICAL FORMS OF HIGH-MOBILITY DNA IN SPINAL-CORD TISSUES OF PARALYZED MICE ARE PRODUCTS OF PREMATURE TERMINATION OF REVERSE TRANSCRIPTION
    Journal of virology
    
    P.F. Szurek e B.R. Brooks, "TS1-INDUCED SPONGIFORM ENCEPHALOMYELOPATHY - PHYSICAL FORMS OF HIGH-MOBILITY DNA IN SPINAL-CORD TISSUES OF PARALYZED MICE ARE PRODUCTS OF PREMATURE TERMINATION OF REVERSE TRANSCRIPTION", Journal of virology, 70(4), 1996, pp. 2230-2236
63. FELLER SE; PASTOR RW; ROJNUCKARIN A; BOGUSZ S; BROOKS BR
    EFFECT OF ELECTROSTATIC FORCE TRUNCATION ON INTERFACIAL AND TRANSPORT-PROPERTIES OF WATER
    Journal of physical chemistry
    
    S.E. Feller et al., "EFFECT OF ELECTROSTATIC FORCE TRUNCATION ON INTERFACIAL AND TRANSPORT-PROPERTIES OF WATER", Journal of physical chemistry, 100(42), 1996, pp. 17011-17020
64. EURENIUS KP; CHATFIELD DC; BROOKS BR; HODOSCEK M
    ENZYME MECHANISMS WITH HYBRID QUANTUM AND MOLECULAR MECHANICAL POTENTIALS .1. THEORETICAL CONSIDERATIONS
    International journal of quantum chemistry
    
    K.P. Eurenius et al., "ENZYME MECHANISMS WITH HYBRID QUANTUM AND MOLECULAR MECHANICAL POTENTIALS .1. THEORETICAL CONSIDERATIONS", International journal of quantum chemistry, 60(6), 1996, pp. 1189-1200
65. FINISON LJ; BROOKS BR; RINGEL SP; MUNSAT TL; NEVILLE HE; MURPHY JR; ENGLAND JD; LEE JY; BRINKMANN JR; ZITER F; ALDERSON MK; PETAJAN JH; GAPPMAIER E; MYLAR D; BRYAN W; HERBELIN J; SMITH P; MILLER RG; ALMADA A; MENDOZA M; YU P; ROELOFS RI; SMITH SA; GRAVES J; SUFIT RL; SANJAK M; COOK T; JUBELT B; HELLER S; CASEY P; ROOS R; SALESARGRUSEO E; RICHMOND I; ANDRES PL; HEDLUND W
    MUSCULAR WEAKNESS ASSESSMENT - USE OF NORMAL ISOMETRIC STRENGTH DATA
    Archives of physical medicine and rehabilitation
    
    L.J. Finison et al., "MUSCULAR WEAKNESS ASSESSMENT - USE OF NORMAL ISOMETRIC STRENGTH DATA", Archives of physical medicine and rehabilitation, 77(12), 1996, pp. 1251-1255
66. BROOKS BR; SANJAK M; RINGEL S; ENGLAND J; BRINKMANN J; PESTRONK A; FLORENCE J; MITSUMOTO H; SZIRONY K; WITTES J; CHARATAN M; STAMBLER N; CEDARBAUM JM
    THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE - ASSESSMENT OF ACTIVITIES OF DAILY LIVING IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
    Archives of neurology
    
    B.R. Brooks et al., "THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE - ASSESSMENT OF ACTIVITIES OF DAILY LIVING IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS", Archives of neurology, 53(2), 1996, pp. 141-147
67. WACLAWIK AJ; FADIC R; LOTZ BP; BEINLICH BR; LEWANDOSKI PJ; SANJAK M; BROOKS BR
    CD8 AND CD4 T-CELL-MEDIATED POLYMYOSITIS COMPLICATING THE HTLV-1 ASSOCIATED MYELOPATHY - QUANTITATIVE-EVALUATION OF CORTICOSTEROID TREATMENT
    Acta neurologica Scandinavica
    
    A.J. Waclawik et al., "CD8 AND CD4 T-CELL-MEDIATED POLYMYOSITIS COMPLICATING THE HTLV-1 ASSOCIATED MYELOPATHY - QUANTITATIVE-EVALUATION OF CORTICOSTEROID TREATMENT", Acta neurologica Scandinavica, 94(2), 1996, pp. 115-119
68. LANDAU WM; DAUBE JR; AMINOFF MJ; BREY RL; BROOKS BR; DEUEL RK; GALABURDA AM; PORTER JA; ROSENBAUM RB; WHITHAM RH; WIGGS JW
    NEUROREALITY .1. DEDICATED DEMOLITION OF THE DECADE OF THE BRAIN - THE GENUINE THREAT TO NEUROLOGIC RESEARCH FROM THE ANIMAL RADICAL RIGHT
    Journal of child neurology
    
    W.M. Landau et al., "NEUROREALITY .1. DEDICATED DEMOLITION OF THE DECADE OF THE BRAIN - THE GENUINE THREAT TO NEUROLOGIC RESEARCH FROM THE ANIMAL RADICAL RIGHT", Journal of child neurology, 10(5), 1995, pp. 343-345
69. BROOKS BR; SHODIS KA; SANJAK M; BELDEN D
    TEMPORAL DISTINCTION OF SPINAL AND BULBAR STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - VALIDATION WITH TIME-TO-FAILURE ANALYSIS EMPLOYING ALS FUNCTIONAL RATING-SCALE
    Annals of neurology
    
    B.R. Brooks et al., "TEMPORAL DISTINCTION OF SPINAL AND BULBAR STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - VALIDATION WITH TIME-TO-FAILURE ANALYSIS EMPLOYING ALS FUNCTIONAL RATING-SCALE", Annals of neurology, 38(2), 1995, pp. 294-294
70. VANN JM; GOLDMAN AJ; SZUREK PF; BROOKS BR
    DEOXYGLUCOSE UPTAKE BY MOUSE ASTROCYTES - EFFECTS OF TEMPERATURE AND RETROVIRUS INFECTION
    Neurochemical research
    
    J.M. Vann et al., "DEOXYGLUCOSE UPTAKE BY MOUSE ASTROCYTES - EFFECTS OF TEMPERATURE AND RETROVIRUS INFECTION", Neurochemical research, 20(9), 1995, pp. 1013-1020
71. CEDARBAUM JM; CHAPMAN C; CHARATAN M; STAMBLER N; ANDREWS L; ZHAN C; RADKA S; MORRISEY D; LAKINGS D; BROOKS BR; SANJAK M; PESTRONK A; FLORENCE J; MITSUMOTO H; SZIRONY K; BITTLE L; RINGEL S; NEVILLE H; BRINKMANN J
    THE PHARMACOKINETICS OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMANCILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS - RELATION TO PARAMETERS OF THE ACUTE-PHASE RESPONSE
    Clinical neuropharmacology
    
    J.M. Cedarbaum et al., "THE PHARMACOKINETICS OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMANCILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS - RELATION TO PARAMETERS OF THE ACUTE-PHASE RESPONSE", Clinical neuropharmacology, 18(6), 1995, pp. 500-514
72. CEDARBAUM JM; CHAPMAN C; CHARATAN M; STAMBLER N; ANDREWS L; ZHAN C; RADKA S; MORRISEY D; LAKINGS D; BROOKS BR; SANJAK M; PESTRONK A; FLORENCE J; MITSUMOTO H; SZIRONY K; BITTLE L; NEVILLE H; RINGEL S; BRINKMANN J; WITTES J
    A PHASE-I STUDY OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
    Clinical neuropharmacology
    
    J.M. Cedarbaum et al., "A PHASE-I STUDY OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS", Clinical neuropharmacology, 18(6), 1995, pp. 515-532
73. BROOKS BR; JANEZIC D; KARPLUS M
    HARMONIC-ANALYSIS OF LARGE SYSTEMS .1. METHODOLOGY
    Journal of computational chemistry
    
    B.R. Brooks et al., "HARMONIC-ANALYSIS OF LARGE SYSTEMS .1. METHODOLOGY", Journal of computational chemistry, 16(12), 1995, pp. 1522-1542
74. JANEZIC D; BROOKS BR
    HARMONIC-ANALYSIS OF LARGE SYSTEMS .2. COMPARISON OF DIFFERENT PROTEIN MODELS
    Journal of computational chemistry
    
    D. Janezic e B.R. Brooks, "HARMONIC-ANALYSIS OF LARGE SYSTEMS .2. COMPARISON OF DIFFERENT PROTEIN MODELS", Journal of computational chemistry, 16(12), 1995, pp. 1543-1553
75. JANEZIC D; VENABLE RM; BROOKS BR
    HARMONIC-ANALYSIS OF LARGE SYSTEMS .3. COMPARISON WITH MOLECULAR-DYNAMICS
    Journal of computational chemistry
    
    D. Janezic et al., "HARMONIC-ANALYSIS OF LARGE SYSTEMS .3. COMPARISON WITH MOLECULAR-DYNAMICS", Journal of computational chemistry, 16(12), 1995, pp. 1554-1566
76. JOHNSON KP; BROOKS BR; COHEN JA; FORD CC; GOLDSTEIN J; LISAK RP; MYERS LW; PANITCH HS; ROSE JW; SCHIFFER RB; VOLLMER T; WEINER LP; WOLINSKY JS; BIRD SJ; CONSTANTINESCU C; KOLSON DL; GONZALEZSCARANO F; BRENNAN D; PFOHL D; MANDLER RN; ROSENBERG GA; JEFFREY C; BARGER GR; GANDHI B; MOORE PM; ROGERS LR; LISAK D; SMITH L; ELLISON GW; BAUMHEFNER RW; CRAIG SL; JALBUT SS; KATZ E; CONWAY KL; BURNS JB; SHIBA C; GIANG DW; PETRIE MD; GUARNACCIA JB; ANDERSON S; MCKEON A; MCCARTHY M; THOMAS AB; VRIESENDORP FJ; AUSTIN SG; LINDSEY JW; DIMACHKIE M; CERRETA E; KACHUCK N; MCCARTHY KA; FLEMING J; PARNELL JH; TAMULEVICH J; WEASLER C; KADOSH S; HALT H; STARK Y; PINCHASI I; SPILLER N; VANDENNOORT S; MILLER A; MELLITS D; HOPKINS J; REINGOLD S; GOMOLIN IH
    COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Neurology
    
    K.P. Johnson et al., "COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL", Neurology, 45(7), 1995, pp. 1268-1276
77. SZUREK P; BROOKS BR
    ENVELOPE GENE ILE25 LOCUS IN TS1 NEUROPATHOGENIC RETROVIRUS-INDUCED SPONGIFORM POLIOENCEPHALOMYELOPATHY DETERMINES ONSET LATENCY OF DISEASEAND APPEARANCE OF NOVEL LOW-MOLECULAR-WEIGHT VIRAL-DNA FORMS INDICATIVE OF INFECTION OF QUIESCENT CNS CELLS
    Neurology
    
    P. Szurek e B.R. Brooks, "ENVELOPE GENE ILE25 LOCUS IN TS1 NEUROPATHOGENIC RETROVIRUS-INDUCED SPONGIFORM POLIOENCEPHALOMYELOPATHY DETERMINES ONSET LATENCY OF DISEASEAND APPEARANCE OF NOVEL LOW-MOLECULAR-WEIGHT VIRAL-DNA FORMS INDICATIVE OF INFECTION OF QUIESCENT CNS CELLS", Neurology, 45(4), 1995, pp. 342-342
78. BROOKS BR
    PHASE-II-III DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL OF SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS
    Neurology
    
    B.R. Brooks, "PHASE-II-III DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL OF SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS", Neurology, 45(4), 1995, pp. 448-448
79. LANDAU WM; DAUBE JR; AMINOFF MJ; BREY RL; BROOKS BR; DEUEL RK; GALABURDA AM; PORTER JA; ROSENBAUM RB; WHITHAM RH; WIGGS JW
    NEUROREALITY .1. DEDICATED DEMOLITION OF THE DECADE OF THE BRAIN - THE GENUINE THREAT TO NEUROLOGIC RESEARCH FROM THE ANIMAL RADICAL RIGHT
    Neurology
    
    W.M. Landau et al., "NEUROREALITY .1. DEDICATED DEMOLITION OF THE DECADE OF THE BRAIN - THE GENUINE THREAT TO NEUROLOGIC RESEARCH FROM THE ANIMAL RADICAL RIGHT", Neurology, 45(4), 1995, pp. 609-610
80. SZUREK PF; BROOKS BR
    DEVELOPMENT OF PHYSICAL FORMS OF UNINTEGRATED RETROVIRAL DNA IN MOUSESPINAL-CORD TISSUE DURING TS1-INDUCED SPONGIFORM ENCEPHALOMYELOPATHY - ELEVATED LEVELS OF A NOVEL SINGLE-STRANDED FORM IN PARALYZED MICE
    Journal of virology
    
    P.F. Szurek e B.R. Brooks, "DEVELOPMENT OF PHYSICAL FORMS OF UNINTEGRATED RETROVIRAL DNA IN MOUSESPINAL-CORD TISSUE DURING TS1-INDUCED SPONGIFORM ENCEPHALOMYELOPATHY - ELEVATED LEVELS OF A NOVEL SINGLE-STRANDED FORM IN PARALYZED MICE", Journal of virology, 69(1), 1995, pp. 348-356
81. ZHANG YH; FELLER SE; BROOKS BR; PASTOR RW
    COMPUTER-SIMULATION OF LIQUID LIQUID INTERFACES .1. THEORY AND APPLICATION TO OCTANE/WATER/
    The Journal of chemical physics
    
    Y.H. Zhang et al., "COMPUTER-SIMULATION OF LIQUID LIQUID INTERFACES .1. THEORY AND APPLICATION TO OCTANE/WATER/", The Journal of chemical physics, 103(23), 1995, pp. 10252-10266
82. FELLER SE; ZHANG YH; PASTOR RW; BROOKS BR
    CONSTANT-PRESSURE MOLECULAR-DYNAMICS SIMULATION - THE LANGEVIN PISTONMETHOD
    The Journal of chemical physics
    
    S.E. Feller et al., "CONSTANT-PRESSURE MOLECULAR-DYNAMICS SIMULATION - THE LANGEVIN PISTONMETHOD", The Journal of chemical physics, 103(11), 1995, pp. 4613-4621
83. CHATFIELD DC; BROOKS BR
    HIV-1 PROTEASE CLEAVAGE MECHANISM ELUCIDATED WITH MOLECULAR-DYNAMICS SIMULATION
    Journal of the American Chemical Society
    
    D.C. Chatfield e B.R. Brooks, "HIV-1 PROTEASE CLEAVAGE MECHANISM ELUCIDATED WITH MOLECULAR-DYNAMICS SIMULATION", Journal of the American Chemical Society, 117(20), 1995, pp. 5561-5572
84. BROOKS BR; SANJAK M; BELDEN D
    QUANTITATIVE NATURAL-HISTORY OF ISOMETRIC STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS AND MULTIPLE-SCLEROSIS - MEGASLOPES NORMALIZED TO A GENDER-SPECIFIED AND AGE-SPECIFIED NORMAL SUBJECT POPULATION DEMONSTRATE GENDER-SPECIFIC REGIONAL DIFFERENCES IN THE COURSE OF AMYOTROPHIC-LATERAL-SCLEROSIS COMPARED WITH MULTIPLE-SCLEROSIS
    Annals of neurology
    
    B.R. Brooks et al., "QUANTITATIVE NATURAL-HISTORY OF ISOMETRIC STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS AND MULTIPLE-SCLEROSIS - MEGASLOPES NORMALIZED TO A GENDER-SPECIFIED AND AGE-SPECIFIED NORMAL SUBJECT POPULATION DEMONSTRATE GENDER-SPECIFIC REGIONAL DIFFERENCES IN THE COURSE OF AMYOTROPHIC-LATERAL-SCLEROSIS COMPARED WITH MULTIPLE-SCLEROSIS", Annals of neurology, 36(2), 1994, pp. 274-274
85. STEINBACH PJ; BROOKS BR
    NEW SPHERICAL-CUTOFF METHODS FOR LONG-RANGE FORCES IN MACROMOLECULAR SIMULATION
    Journal of computational chemistry
    
    P.J. Steinbach e B.R. Brooks, "NEW SPHERICAL-CUTOFF METHODS FOR LONG-RANGE FORCES IN MACROMOLECULAR SIMULATION", Journal of computational chemistry, 15(7), 1994, pp. 667-683
86. TULUNAYKEESEY U; BROOKS BR; KUKUJAN R; HOEVE JNV
    EFFECT OF ORIENTATION ON SPATIOTEMPORAL CONTRAST SENSITIVITY IN MULTIPLE-SCLEROSIS
    Vision research
    
    U. Tulunaykeesey et al., "EFFECT OF ORIENTATION ON SPATIOTEMPORAL CONTRAST SENSITIVITY IN MULTIPLE-SCLEROSIS", Vision research, 34(1), 1994, pp. 123-136
87. BROOKS BR; SANJAK M; NEVILLE H; RINGEL S; BRINKMANN J; PESTRONK A; FLORENCE J; MITSUMOTO H; SZIRONY K; WITTES J; BRITTAIN E; STAMBLER N; CHARATAN M; CHAPMAN C; CEDARBAUM JM
    ANALYZING THE EFFECT OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR(RHCNTF) ON MUSCLE STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
    Neurology
    
    B.R. Brooks et al., "ANALYZING THE EFFECT OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR(RHCNTF) ON MUSCLE STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)", Neurology, 44(4), 1994, pp. 10000166-10000166
88. CEDARBAUM JM; WITTES J; BRITTAIN E; BROOKS BR; SANJAK M; NEVILLE H; RINGEL S; BRINKMANN J; PESTRONK A; FLORENCE J; MITSUMOTO H; SZIRONY K; STAMBLER N; CHARATAN M; CHAPMAN C
    CORRELATION BETWEEN RATES OF CHANGE IN FUNCTIONAL RATING-SCALES AND MUSCLE STRENGTH MEASURES IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS
    Neurology
    
    J.M. Cedarbaum et al., "CORRELATION BETWEEN RATES OF CHANGE IN FUNCTIONAL RATING-SCALES AND MUSCLE STRENGTH MEASURES IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS", Neurology, 44(4), 1994, pp. 10000256-10000257
89. VANN J; GOLDMAN AJ; SZUREK P; BROOKS BR
    REGION-SPECIFIC ALTERATIONS IN MOUSE ASTROCYTE ATP CONTENT INDUCED BYNEUROPATHOGENIC TS1 MUTANT OF MOLONEY LEUKEMIA-VIRUS INFECTION IN-VITRO
    Neurology
    
    J. Vann et al., "REGION-SPECIFIC ALTERATIONS IN MOUSE ASTROCYTE ATP CONTENT INDUCED BYNEUROPATHOGENIC TS1 MUTANT OF MOLONEY LEUKEMIA-VIRUS INFECTION IN-VITRO", Neurology, 44(4), 1994, pp. 10000319-10000320
90. SZUREK P; BROOKS BR
    RETROVIRAL ENVELOPE (ENV)-SPECIFIC VIRAL-DNA FORMS IN TS1-INDUCED SPONGIFORM POLIOENCEPHALOMYELOPATHY - NEW LOW-MOLECULAR-WEIGHT VIRAL-DNA FORM OCCURS WITH THE APPEARANCE OF CLINICAL-DISEASE
    Neurology
    
    P. Szurek e B.R. Brooks, "RETROVIRAL ENVELOPE (ENV)-SPECIFIC VIRAL-DNA FORMS IN TS1-INDUCED SPONGIFORM POLIOENCEPHALOMYELOPATHY - NEW LOW-MOLECULAR-WEIGHT VIRAL-DNA FORM OCCURS WITH THE APPEARANCE OF CLINICAL-DISEASE", Neurology, 44(4), 1994, pp. 10000396-10000396
91. BROOKS BR
    EL-ESCORIAL WORLD FEDERATION OF NEUROLOGY CRITERIA FOR THE DIAGNOSIS OF AMYOTROPHIC-LATERAL-SCLEROSIS
    Journal of the neurological sciences
    
    B.R. Brooks, "EL-ESCORIAL WORLD FEDERATION OF NEUROLOGY CRITERIA FOR THE DIAGNOSIS OF AMYOTROPHIC-LATERAL-SCLEROSIS", Journal of the neurological sciences, 124, 1994, pp. 96-107
92. DURELL SR; BROOKS BR; BENNAIM A
    SOLVENT-INDUCED FORCES BETWEEN 2 HYDROPHILIC GROUPS
    Journal of physical chemistry
    
    S.R. Durell et al., "SOLVENT-INDUCED FORCES BETWEEN 2 HYDROPHILIC GROUPS", Journal of physical chemistry, 98(8), 1994, pp. 2198-2202
93. STEINBACH PJ; BROOKS BR
    PROTEIN SIMULATION BELOW THE GLASS-TRANSITION TEMPERATURE - DEPENDENCE ON COOLING PROTOCOL
    Chemical physics letters
    
    P.J. Steinbach e B.R. Brooks, "PROTEIN SIMULATION BELOW THE GLASS-TRANSITION TEMPERATURE - DEPENDENCE ON COOLING PROTOCOL", Chemical physics letters, 226(5-6), 1994, pp. 447-452
94. STEINBACH PJ; BROOKS BR
    THE GLASS-TRANSITION IN MYOGLOBIN
    Biophysical journal
    
    P.J. Steinbach e B.R. Brooks, "THE GLASS-TRANSITION IN MYOGLOBIN", Biophysical journal, 66(2), 1994, pp. 10000363-10000363
95. BROOKS BR; LEWIS D; RAWLING J; SANJAK M; BELDEN D; HAKIM H; DETAN Y; SUFIT RL; GAFFNEY J; DEPAUL R
    NATURAL-HISTORY OF AMYOTROPHIC-LATERAL-SCLEROSIS - EFFECT OF SITE OF ONSET AND TIME AFTER ONSET ON SAMPLE-SIZE CALCULATIONS FOR CLINICAL THERAPEUTIC TRIALS EMPLOYING SLOPE OF STRENGTH LOSS
    Annals of neurology
    
    B.R. Brooks et al., "NATURAL-HISTORY OF AMYOTROPHIC-LATERAL-SCLEROSIS - EFFECT OF SITE OF ONSET AND TIME AFTER ONSET ON SAMPLE-SIZE CALCULATIONS FOR CLINICAL THERAPEUTIC TRIALS EMPLOYING SLOPE OF STRENGTH LOSS", Annals of neurology, 34(2), 1993, pp. 297-297
96. LEWIS DH; BELDEN D; RAWLING J; CAREY P; SANJAK M; BROOKS BR
    STATISTICAL-ANALYSIS OF STRENGTH AND FUNCTION IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
    Neurology
    
    D.H. Lewis et al., "STATISTICAL-ANALYSIS OF STRENGTH AND FUNCTION IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)", Neurology, 43(4), 1993, pp. 258-258
97. BROOKS BR; SANJAK M; MITSUMOTO H; SZIRONY K; NEVILLE H; RINGEL S; BRINKMANN J; PESTRONK A; FLORENCE J; CEDARBAUM JM; CHARATAN M; STAMBLER N; WITTES J; BRITTAIN E
    RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS - PHASE-I-II SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDIES
    Neurology
    
    B.R. Brooks et al., "RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS - PHASE-I-II SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDIES", Neurology, 43(4), 1993, pp. 416-416
98. CEDARBAUM JM; CHARATAN M; STAMBLER N; BROOKS BR; SANJAK M; MITSUMOTO WH; SZIRONY K; NEVILLE H; RINGEL S; BRINKMANN J; PESTRONK A; FLORENCE J; WITTES J; BRITTAIN E
    THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE (ALSFRS) - PROSPECTIVE VALIDATION AND CHANGES OVER TIME
    Neurology
    
    J.M. Cedarbaum et al., "THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE (ALSFRS) - PROSPECTIVE VALIDATION AND CHANGES OVER TIME", Neurology, 43(4), 1993, pp. 417-417
99. STEINBACH PJ; BROOKS BR
    PROTEIN HYDRATION ELUCIDATED BY MOLECULAR-DYNAMICS SIMULATION
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    P.J. Steinbach e B.R. Brooks, "PROTEIN HYDRATION ELUCIDATED BY MOLECULAR-DYNAMICS SIMULATION", Proceedings of the National Academy of Sciences of the United Statesof America, 90(19), 1993, pp. 9135-9139
100. DEPAUL R; BROOKS BR
     MULTIPLE OROFACIAL INDEXES IN AMYOTROPHIC-LATERAL-SCLEROSIS
     Journal of speech and hearing research
     
     R. Depaul e B.R. Brooks, "MULTIPLE OROFACIAL INDEXES IN AMYOTROPHIC-LATERAL-SCLEROSIS", Journal of speech and hearing research, 36(6), 1993, pp. 1158-1167